US-based CBD producer Folium Biosciences is looking to tap Asian markets by creating a dedicated stalk extraction line which it believes will meet the strict regulatory requirements of Japan and South Korea
Submit your access request to explore how it can streamlines access to critical cannabis insights
"*" indicates required fields